Noble Capital Markets’ NobleCon 18,
“We are excited to update investors regarding Wesana’s most recent interactions with the FDA. Connecting with key stakeholders and community members about our novel drug development program and the defined pathway forward to regulatory approval is incredibly important to us,” said
To find out more or to arrange a meeting with
About
Wesana Health helps people transcend barriers in mental health and performance. We innovate in care development through our therapies and patent-pending protocols, and in care delivery through activating a new multidisciplinary, technology-supported clinical model. Learn more at www.wesanahealth.com.
Investor Relations:
Email: IR@wesanahealth.com
Phone: 702-329-8038
Media Contacts:
Email: media@wesanahealth.com
Phone: 917-653-4613
Source:
2022 GlobeNewswire, Inc., source